NIH-funded research R01 grant

How lifelong economic hardship might speed biological aging and affect thinking in midlife

Official title: Administrative Supplement: Accelerated Epigenetic Aging as a Mechanism in Lifespan Socioeconomic Effects on Midlife Cognitive Decline

Funded at University of Pittsburgh at Pittsburgh · NIH-11411039 · Data updated 2026-11-12

This project looks at whether limited resources across life speed up biological 'epigenetic' aging and lead to worse thinking and memory in adults during midlife.

More Aging research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Pittsburgh at Pittsburgh
NIH-funded
Lab location1 site (Pittsburgh, United States)
Project startApril 1, 2025
Project endDecember 31, 2029
Funding year2026
Award (this year)$111,298
NIH project number3R01AG086346-02S1
Project IDNIH-11411039 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are adults in midlife who can share their childhood and adult socioeconomic history and provide biological samples for epigenetic testing.

Less likely to help

People seeking immediate treatments for dementia symptoms or those who cannot provide life-course history or biological samples are unlikely to get direct benefit from this project.

What this research studies

From my point of view, researchers will combine information about childhood and adult socioeconomic conditions with biological measures of epigenetic aging and repeated thinking tests to see how disadvantage relates to midlife cognition. They will compare four life-course ideas — childhood-sensitive periods, total accumulated exposure, adult pathways, and social mobility — to find when hardship matters most. The work uses existing long-term study data and biological samples to follow changes over time. The team links neighborhood and personal economic history with blood-based epigenetic markers and cognitive change patterns.

Why it matters

Potential benefit: If successful, this could point to when and how economic hardship speeds biological aging and contributes to earlier cognitive decline, helping target prevention and public-health efforts.

How similar studies have gone: Other studies have linked socioeconomic disadvantage to poorer cognition and linked epigenetic age to aging outcomes, but directly connecting life-course timing of disadvantage to epigenetic aging and midlife cognitive decline is a newer approach.

Where this research is happening

  • University of Pittsburgh at Pittsburgh
    Pittsburgh, United States
    Active

Researchers

  • Principal investigator: Reed, Rebecca G — University of Pittsburgh at Pittsburgh
  • Study coordinator: Reed, Rebecca G

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.